Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine:
- the largest dose of AQ4N that can be safely given once a week for three weeks out of a 4
week cycle
- the side effects of AQ4N when given on the above schedule
- how much AQ4N is in the blood and urine at specific times after administration and how
the body get rids of AQ4N
- if AQ4N helps treat cancer